Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

Analysis of B4GALT1/GGTB2 by ELISA (CAT#: STEM-MB-1581-LGZ)

Introduction

Beta-1, 4-galactosyltransferase 1 (B4GALT1), one of seven beta-1, 4-galactosyltransferases, is commonly found in trans-Golgi complexes and transfers galactose to oligosaccharides. According to sequence similarity, B4GALTs can be divided into 4 groups: B4GALT1 and B4GALT2, B4GALT3 and B4GALT4, B4GALT5 and B4GALT6, and B4GALT7. Of these seven enzymes, B4GALT1 is unique in that it can be expressed as a membrane-bound or secreted form. The secreted form exists only in lactating mammary gland tissue, where the enzyme forms a heterodimer with α-lactalbumin, which catalyzes the synthesis of lactose. The membrane-bound form resides either in the Golgi apparatus, where the enzyme adds galactose to N-acetylglucosamine residues, or on the cell surface, during a variety of cell-cell and cell-matrix interactions, The enzyme functions as a recognition molecule by binding to specific oligosaccharide ligands on opposing cells or the extracellular matrix. These two enzyme forms arise from alternate transcription initiation sites and post-translational processing. Loss of B4GALT1 causes an inborn error of 2D-type glycosylation.




Principle

Enzyme-linked immunosorbent assay (ELISA) is an enzyme-labeled solid phase immunoassay technique. Its basic principle is to bind the antigen (or antibody) to the solid phase carrier, and the antigen (or antibody) and a certain enzyme link to enzyme labeled antigen (or antibody). During detection, the sample to be tested and the enzymic antigen (or antibody) react with the antigen (or antibody) on the solid phase carrier according to certain procedures, and then remove the unreacted part by washing method. After adding the substrate, the substrate is catalyzed by the enzyme on the solid phase carrier to produce colored substances. Through qualitative or quantitative detection of the amount of colored products, the content of the substance to be measured in the sample can be determined.

Applications

Implicated in congenital disorder of glycosylation and congenital disorder of glycosylation type IId.

Procedure

1. Add standards or samples to each well and incubate.
2. Pour off the liquid in the well, biotinylated antibody working solution and incubate.
3. Add enzyme conjugate working solution and incubate.
4. Add substrate TMB and incubate.
5. Add stop solution and measure OD value.
6. Calculation of results.

Materials

• Sample Type: Serum, plasma, cell culture supernatant and other biological samples
Advertisement